First year experience of rotavirus immunisation programme in Finland.

[1]  A. Garcia-Basteiro,et al.  Hospitalizations due to rotavirus gastroenteritis in Catalonia, Spain, 2003-2008 , 2011, BMC Research Notes.

[2]  J. Hadler,et al.  Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008. , 2011, Vaccine.

[3]  A. Curns,et al.  Effectiveness of Pentavalent Rotavirus Vaccine Against Severe Disease , 2011, Pediatrics.

[4]  E. Oger,et al.  Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study. , 2011, Vaccine.

[5]  P. van Damme,et al.  Rotavirus Vaccines in Belgium: Policy and Impact , 2011, The Pediatric infectious disease journal.

[6]  E. Shapiro,et al.  Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. , 2010, Vaccine.

[7]  V. Baldo,et al.  Hospitalisation for rotavirus gastroenteritis in the paediatric population in the Veneto Region, Italy , 2010, BMC public health.

[8]  Manish M Patel,et al.  Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United States , 2010, Pediatrics.

[9]  M. Kundi,et al.  Universal Mass Vaccination Against Rotavirus Gastroenteritis: Impact on Hospitalization Rates in Austrian Children , 2009, The Pediatric infectious disease journal.

[10]  Manish M Patel,et al.  Decline and Change in Seasonality of US Rotavirus Activity After the Introduction of Rotavirus Vaccine , 2009, Pediatrics.

[11]  M. Dinubile,et al.  Decline in Cases of Rotavirus Gastroenteritis Presenting to The Children's Hospital of Philadelphia after Introduction of a Pentavalent Rotavirus Vaccine , 2009, Clinical and Vaccine Immunology.

[12]  Felix Espinoza,et al.  Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study , 2008, The Lancet.

[13]  T. Vesikari,et al.  Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study , 2007, The Lancet.

[14]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[15]  J. Heyse,et al.  Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.

[16]  Timo Vesikari,et al.  Burden of Rotavirus Disease in European Union Countries , 2006, The Pediatric infectious disease journal.

[17]  T. Vesikari,et al.  Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants , 2004, The Pediatric infectious disease journal.

[18]  Mark A. Miller,et al.  Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.

[19]  C. von Bonsdorff,et al.  Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.